A131030 Overzicht aandelen
OPTUS Pharmaceutical Co., Ltd. levert oogheelkundige oplossingen in Zuid-Korea.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 4/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 1/6 |
OPTUS Pharmaceutical Co., Ltd. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ₩6,380.00 |
| 52 Week Hoogtepunt | ₩10,430.00 |
| 52 Week Laag | ₩4,900.00 |
| Bèta | 0.50 |
| 11 maand verandering | -8.33% |
| 3 maanden verandering | -3.77% |
| 1 Jaar Verandering | 25.59% |
| 33 jaar verandering | -8.73% |
| 5 jaar verandering | -18.41% |
| Verandering sinds IPO | 19.70% |
Recent nieuws en updates
Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal
Aug 07
There's Reason For Concern Over OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Massive 28% Price Jump
Jun 27Recent updates
Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal
Aug 07There's Reason For Concern Over OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Massive 28% Price Jump
Jun 27There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise
Mar 25OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality
Mar 13The Returns On Capital At DHP Korea (KOSDAQ:131030) Don't Inspire Confidence
Apr 05DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit
Mar 09DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 10
How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 12Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?
Dec 08Rendement voor aandeelhouders
| A131030 | KR Medical Equipment | KR Markt | |
|---|---|---|---|
| 7D | -2.9% | -3.1% | -1.2% |
| 1Y | 25.6% | 15.3% | 4.8% |
Rendement versus industrie: A131030 exceeded the KR Medical Equipment industry which returned 15.3% over the past year.
Rendement versus markt: A131030 exceeded the KR Market which returned 4.8% over the past year.
Prijsvolatiliteit
| A131030 volatility | |
|---|---|
| A131030 Average Weekly Movement | 7.2% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in KR Market | 12.2% |
| 10% least volatile stocks in KR Market | 3.5% |
Stabiele aandelenkoers: A131030 has not had significant price volatility in the past 3 months compared to the KR market.
Volatiliteit in de loop van de tijd: A131030's weekly volatility (7%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2002 | n/a | Dong-Hwa Han | www.optuspharm.com |
OPTUS Pharmaceutical Co., Ltd. levert oogheelkundige oplossingen in Zuid-Korea. Het bedrijf biedt producten voor droge ogen, antibiotica, anti-allergische middelen, steroïden, glaucoom en retinopathie. Het levert ook ETC-, OTC-, cosmetica-, gezondheids- en andere producten, evenals oogdruppels en oogverzorgingsproducten onder de merknaam OEU&.
OPTUS Pharmaceutical Co., Ltd. Samenvatting
| A131030 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ₩103.06b |
| Inkomsten(TTM) | ₩10.25b |
| Inkomsten(TTM) | ₩77.79b |
10.1x
Koers/Winstverhouding1.3x
P/S-verhoudingIs A131030 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| A131030 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ₩77.79b |
| Kosten van inkomsten | ₩34.78b |
| Brutowinst | ₩43.02b |
| Overige uitgaven | ₩32.77b |
| Inkomsten | ₩10.25b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 634.40 |
| Brutomarge | 55.30% |
| Nettowinstmarge | 13.17% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde A131030 op de lange termijn?
Bekijk historische prestaties en vergelijking